Compare TNET & LMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TNET | LMAT |
|---|---|---|
| Founded | 1988 | 1983 |
| Country | United States | United States |
| Employees | 2700 | N/A |
| Industry | Business Services | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 2.2B |
| IPO Year | 2000 | 2006 |
| Metric | TNET | LMAT |
|---|---|---|
| Price | $45.54 | $91.76 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 5 | 5 |
| Target Price | $65.80 | ★ $105.80 |
| AVG Volume (30 Days) | ★ 342.8K | 238.2K |
| Earning Date | 04-30-2026 | 05-05-2026 |
| Dividend Yield | ★ 2.57% | 0.93% |
| EPS Growth | N/A | ★ 30.57 |
| EPS | ★ 1.90 | 0.68 |
| Revenue | ★ $5,010,000,000.00 | $249,602,000.00 |
| Revenue This Year | N/A | $14.21 |
| Revenue Next Year | $3.30 | $8.88 |
| P/E Ratio | ★ $24.51 | $137.34 |
| Revenue Growth | N/A | ★ 13.53 |
| 52 Week Low | $33.67 | $79.01 |
| 52 Week High | $76.09 | $118.01 |
| Indicator | TNET | LMAT |
|---|---|---|
| Relative Strength Index (RSI) | 50.50 | 36.97 |
| Support Level | $34.47 | $89.31 |
| Resistance Level | $45.62 | $92.25 |
| Average True Range (ATR) | 1.96 | 2.75 |
| MACD | -0.25 | 0.31 |
| Stochastic Oscillator | 5.05 | 20.66 |
Trinet Group Inc provides human resources solutions for small and medium-sized businesses through technology-enabled services. Its offerings include human capital expertise, employee benefits such as health insurance and retirement plans, payroll and payroll tax administration, risk mitigation, and compliance consulting. The company provides its services through professional employer organization (PEO) services delivered via a co-employment model, as well as administrative services organization (ASO) offerings. The majority of the company's revenue is derived from the insurance-related billings and administrative fees collected from PEO clients.
LeMaitre Vascular Inc is a provider of medical devices and human tissue cryopreservation services mainly used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser extent, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons. Its diversified portfolio consists of branded products used in arteries and veins that are well known to vascular surgeons. It operates across the Americas, Europe, the Middle East and Africa, and Asia Pacific, with the majority of its revenue generated from the Americas.